Your doctor says your cholesterol is "fine." Your total cholesterol number is under 200. You leave the appointment reassured.
But total cholesterol is arguably the least useful number in a lipid panel. It's a composite figure that bundles together protective HDL with atherogenic LDL in a single number, and treating them as equivalent tells you almost nothing about your actual cardiovascular risk. Men who have heart attacks often have "normal" total cholesterol. The more predictive markers are in a different tier of testing that most annual physicals never order.
Why LDL Cholesterol Is Also Incomplete
LDL cholesterol (LDL-C) is better than total cholesterol but still misleading for one critical reason: it measures the amount of cholesterol carried in LDL particles, not the number of particles.
Two men can have identical LDL-C readings of 130 mg/dL. But one might have 900 nmol/L of LDL particles (large, fluffy, less atherogenic) while the other has 1800 nmol/L (small, dense, highly atherogenic). The second man has twice the arterial exposure even though his LDL cholesterol looks the same.
This is not a fringe hypothesis — the discordance between LDL-C and LDL particle number is well-established and directly relevant to risk stratification.
Related: Our Biological Age Calculator can help you apply these ideas. For the complete picture, see our Heart & Cardiovascular Health guide and Men's Health Optimization by Decade.
ApoB: The Best Single Lipid Marker
Apolipoprotein B (ApoB) is the protein that coats every atherogenic lipoprotein particle — LDL, VLDL, and IDL all carry exactly one ApoB molecule per particle. This makes ApoB a near-perfect count of atherogenic particles in your blood.
One ApoB measurement captures the full atherogenic burden that LDL-C approximates poorly. When LDL-C and ApoB diverge (as they often do in men with insulin resistance, high triglycerides, or metabolic syndrome), ApoB is the more predictive marker.
Optimal range: Under 80 mg/dL for standard risk; under 70 mg/dL for elevated risk Normal reference range: Under 100-130 mg/dL (this is the disease-avoidance threshold, not the optimum)
ApoB is increasingly considered the single best routine lipid marker by cardiovascular researchers. Multiple expert consensus statements now recommend it over LDL-C for risk assessment. Despite this, it's still not routinely ordered in most annual physicals. You may need to request it specifically.
LDL Particle Number (LDL-P)
LDL-P is a direct measurement of LDL particle count, typically measured by NMR spectroscopy (nuclear magnetic resonance) in tests like the NMR LipoProfile. It provides the same atherogenic particle counting information as ApoB but at higher cost and complexity.
If you can only run one test, ApoB is more accessible and nearly as informative as LDL-P. They track together closely in most populations.
Optimal range: Under 1000 nmol/L
Lipoprotein(a): The Genetic Wild Card
Lp(a) is a modified LDL particle with an additional protein (apolipoprotein(a)) attached. It's almost entirely genetically determined — diet and exercise have minimal effect on it. Elevated Lp(a) is an independent cardiovascular risk factor, meaning it predicts risk above and beyond what LDL, ApoB, and other standard markers capture.
Approximately 20-25% of the population has elevated Lp(a) (above 50 mg/dL or 125 nmol/L). If you have a family history of early cardiovascular disease and otherwise healthy lipids, elevated Lp(a) is often the explanation.
Testing: A single lifetime measurement is sufficient — Lp(a) doesn't change much. Test once in your 30s and factor it into your long-term risk picture. What to do if elevated: While Lp(a) itself isn't modifiable through current over-the-counter interventions, knowing it's elevated changes how aggressively you should manage other risk factors.
Triglycerides and the TG/HDL Ratio
Fasting triglycerides are often underappreciated. Elevated triglycerides (above 150 mg/dL) reflect excess carbohydrate and caloric intake relative to your metabolic capacity, and they are directly associated with more small, dense LDL particles.
The triglyceride-to-HDL ratio (TG/HDL) is a useful proxy for insulin resistance and small, dense LDL prevalence:
| TG/HDL Ratio | Interpretation |
|---|---|
| Under 2.0 | Low risk; predominantly large LDL |
| 2.0 – 4.0 | Moderate; mixed particle pattern |
| Above 4.0 | Elevated; suggests insulin resistance, small dense LDL |
Optimal triglycerides: Under 80 mg/dL (not just under 150) Optimal HDL: Above 50 mg/dL for men
Small Dense LDL (sdLDL)
Not widely ordered but worth knowing about. Small, dense LDL particles are more atherogenic than large ones because they more easily penetrate arterial walls and are more susceptible to oxidation. The TG/HDL ratio is the most practical proxy, but direct sdLDL measurement is available through specialty labs.
How to Get These Tests
Most of these markers are not standard on a basic lipid panel. Options:
- Request from your physician: ApoB, Lp(a), and advanced particle sizing can be ordered by most doctors. Some may require explanation or may not be covered by insurance without a documented indication.
- Direct-to-consumer labs: Services like Cleveland HeartLab, Boston Heart Diagnostics, or InsideTracker include advanced lipid markers in their panels.
- Self-order: Quest and LabCorp offer many of these tests for direct ordering in most states.
Advanced lipid results should be reviewed in the context of your full clinical picture — family history, blood pressure, metabolic markers, and lifestyle factors. A single elevated marker doesn't define your risk in isolation.
Pros
- +ApoB is a single, affordable test that captures atherogenic particle burden more accurately than LDL-C
- +Lp(a) testing is a one-time test that reveals a major genetic risk factor many people don't know they carry
- +TG/HDL ratio adds meaningful context using numbers already in a standard panel
- +Advanced lipid testing is increasingly available through direct-to-consumer services
- +These markers are measurable, trackable, and respond to interventions over 12-16 week experiment cycles
Cons
- -Many physicians still rely on LDL-C and don't routinely order advanced markers
- -Insurance coverage is inconsistent — you may pay out of pocket
- -Results require context: a single elevated number doesn't translate directly to risk without clinical history
- -Lp(a) isn't modifiable, which can feel frustrating even though knowing it is valuable
- -Interpreting discordance between LDL-C and ApoB requires some education
Be the first to try Prova
We're building an app to track whether lipid-panel-tracking actually works. Join the waitlist.
The Bottom Line
Total cholesterol is a relic. LDL cholesterol is a rough proxy. The markers that give you a real picture of cardiovascular risk are ApoB, LDL particle count, Lp(a), and the triglyceride-to-HDL ratio. If you're investing in your long-term health, these are the numbers worth tracking — not just the ones that appear on your standard annual panel. Request them, understand them, and use them to evaluate whether the changes you're making are moving the right needles.